ClinicalTrials.gov Registration Number: NCT00130611.
B-type natriuretic peptide in the evaluation and management of dyspnoea in primary care
Version of Record online: 12 JUN 2012
© 2012 The Association for the Publication of the Journal of Internal Medicine
Journal of Internal Medicine
Volume 272, Issue 5, pages 504–513, November 2012
How to Cite
Burri, E., Hochholzer, K., Arenja, N., Martin-Braschler, H., Kaestner, L., Gekeler, H., Hatziisaak, T., Büttiker, M., Fräulin, A., Potocki, M., Breidthardt, T., Reichlin, T., Socrates, T., Twerenbold, R. and Mueller, C. (2012), B-type natriuretic peptide in the evaluation and management of dyspnoea in primary care. Journal of Internal Medicine, 272: 504–513. doi: 10.1111/j.1365-2796.2012.02552.x
These findings were presented in part as a ‘Late Breaking Clinical Trial’ during the Scientific Session at the meeting of the Heart Failure Association of the European Society of Cardiology, June 2010 in Berlin, Germany.
- Issue online: 22 OCT 2012
- Version of Record online: 12 JUN 2012
- Accepted manuscript online: 2 MAY 2012 10:26AM EST
Table S1. Investigations during 3 monthsafter presentation/enrolment.
|joim2552_sm_Table1S.docx||16K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.